about
Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. T...
Read More7,809 XNAS Volume
XNAS 16 May, 2025 5:30 PM (EDT)
Board Meeting
The next board meeting for Nanobiotix - ADR is on 22 May 2025 for the purpose of Nanobiotix SA First Quarter Earnings Results for 2025
See details
Not Eligible
Expensive Valuation
Technically Neutral
Nanobiotix - ADR Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..